astemizole has been researched along with calcitriol in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Avila, E; Barrera, D; Camacho, J; Díaz, L; Gamboa-Domínguez, A; García-Becerra, R; García-Quiroz, J; Halhali, A; Larrea, F; Medina-Franco, H; Ordaz-Rosado, D; Rivas-Suárez, M; Rodríguez, P; Santos, N | 1 |
| Avila, E; Barrera, D; Camacho, J; Díaz, L; Esparza-López, J; Gamboa-Domínguez, A; García-Becerra, R; García-Quiroz, J; Halhali, A; Ibarra-Sánchez, MJ; Larrea, F; Ordaz-Rosado, D; Santos-Martínez, N; Villanueva, O | 1 |
4 other study(ies) available for astemizole and calcitriol
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Astemizole synergizes calcitriol antiproliferative activity by inhibiting CYP24A1 and upregulating VDR: a novel approach for breast cancer therapy.
Topics: Antineoplastic Agents; Astemizole; Blotting, Western; Breast Neoplasms; Calcitriol; Calcium Channel Agonists; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Down-Regulation; Drug Synergism; Ether-A-Go-Go Potassium Channels; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Ki-67 Antigen; Models, Genetic; Receptors, Calcitriol; Reverse Transcriptase Polymerase Chain Reaction; Steroid Hydroxylases; Tumor Cells, Cultured; Up-Regulation; Vitamin D3 24-Hydroxylase | 2012 |
In vivo dual targeting of the oncogenic Ether-à-go-go-1 potassium channel by calcitriol and astemizole results in enhanced antineoplastic effects in breast tumors.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Astemizole; Breast Neoplasms; Calcitriol; Cell Line, Tumor; Drug Synergism; Ether-A-Go-Go Potassium Channels; Female; Humans; Mice; Mice, Nude; Neoplasm Transplantation | 2014 |